Healthscope Ltd (HSO):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Healthscope Ltd (HSO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11503
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Healthscope Ltd (Healthscope) is an integrated healthcare provider that provides healthcare services through the ownership and management of hospitals and pathology laboratories. The company operates through private hospitals in Australia and pathology laboratories in New Zealand. It provides a range of specialist orientated, multi-disciplinary healthcare services including acute, medical, maternity, mental health and rehabilitation services. Healthscope also provides pathology diagnostic services in New Zealand. The company also provides veterinary pathology services in New Zealand through Gribbles Veterinary. The company operates in Australia, New Zealand and South East Asia. Healthscope is headquartered in Melbourne, Victoria, Australia.

Healthscope Ltd (HSO) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Healthscope Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Healthscope Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Healthscope Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Healthscope Ltd, Medical Devices Deals, 2012 to YTD 2018 8
Healthscope Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Healthscope Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Equity Offering 10
Healthscope Prices IPO 10
Asset Transactions 12
Sonic Healthcare Receives ACCC Approval To Acquire Pathology Business In Australian Capital Territory And Southern Tablelands From Healthscope 12
Acquisition 14
HCA Holdings Rumored To Bid For Healthscope For US$4.5 Billion 14
Healthscope Ltd – Key Competitors 16
Healthscope Ltd – Key Employees 17
Healthscope Ltd – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 20
Financial Announcements 20
Feb 15, 2018: Healthscope 2018 First Half Results 20
Aug 23, 2017: Healthscope 2017 Full Year Results 23
Corporate Communications 26
Jan 08, 2018: Healthscope Appoints Michael Stanford To Board 26
Apr 03, 2017: Gordon Ballantyne to succeed Robert Cooke as Healthscope Managing Director and CEO 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Healthscope Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Healthscope Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Healthscope Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Healthscope Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Healthscope Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Healthscope Ltd, Medical Devices Deals, 2012 to YTD 2018 8
Healthscope Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Healthscope Prices IPO 10
Sonic Healthcare Receives ACCC Approval To Acquire Pathology Business In Australian Capital Territory And Southern Tablelands From Healthscope 12
HCA Holdings Rumored To Bid For Healthscope For US$4.5 Billion 14
Healthscope Ltd, Key Competitors 16
Healthscope Ltd, Key Employees 17
Healthscope Ltd, Subsidiaries 18

List of Figures
Healthscope Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Healthscope Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Healthscope Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Healthscope Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Healthscope Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Healthscope Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Healthscope Ltd, Medical Devices Deals, 2012 to YTD 2018 8

★海外企業調査レポート[Healthscope Ltd (HSO):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Taiwan Sugar Corp:企業の戦略的SWOT分析
    Taiwan Sugar Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Aviva Ltd.:企業の戦略・SWOT・財務情報
    Aviva Ltd. - Strategy, SWOT and Corporate Finance Report Summary Aviva Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Blue Cross and Blue Shield of Florida Inc:企業の戦略的SWOT分析
    Blue Cross and Blue Shield of Florida Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Kepler Weber S.A. (KEPL3):企業の財務・戦略的SWOT分析
    Kepler Weber S.A. (KEPL3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • James Halstead PLC (JHD):企業の財務・戦略的SWOT分析
    Summary James Halstead PLC (James Halstead) is a manufacturer and distributor of flooring products that provides commercial building equipment and flooring products. The company provides manufacturing of commercial, contract and consumer floorings. It also offers dyeing, finishing and later waterpro …
  • REVA Medical Inc (RVA):製品パイプライン分析
    Summary REVA Medical Inc (REVA) is a medical device company that develops minimally invasive medical devices. The company’s product includes bioresorbable polymers. Its bioresorbable polymers can be applied to a variety of medical applications. REVA’s fantom sirolimus-eluting bioresorbable scaffold …
  • Daepyung Co., Ltd.:戦略・SWOT・企業財務分析
    Daepyung Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Daepyung Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Vestel Elektronik Sanayi Ve Ticaret AS:企業の戦略・SWOT・財務分析
    Vestel Elektronik Sanayi Ve Ticaret AS - Strategy, SWOT and Corporate Finance Report Summary Vestel Elektronik Sanayi Ve Ticaret AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Meggitt Training Systems, Inc.:企業の戦略・SWOT・財務情報
    Meggitt Training Systems, Inc. - Strategy, SWOT and Corporate Finance Report Summary Meggitt Training Systems, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Energen Corp (EGN):石油・ガス:M&Aディール及び事業提携情報
    Summary Energen Corp (Energen) is an oil and gas company that offers exploration and production programs. The company through its subsidiary, Energen Resources Corporation, is involved in the development, acquisition, exploration, and production of oil, natural gas, and natural gas liquids located i …
  • SDIX LLC:医療機器:M&Aディール及び事業提携情報
    Summary SDIX LLC (SDIX), a subsidiary of OriGene Technologies Inc, is an immuno-solutions company that develops antibody-based solutions. The company provides IVD solutions and premade antibiotics, among others. Its IVD solutions provide co-development of analyte-specific reagents, diagnostic menu e …
  • Stellar Resources Limited:企業の戦略・SWOT・財務情報
    Stellar Resources Limited - Strategy, SWOT and Corporate Finance Report Summary Stellar Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • BOE Technology Group Co Ltd:企業の戦略・SWOT・財務情報
    BOE Technology Group Co Ltd - Strategy, SWOT and Corporate Finance Report Summary BOE Technology Group Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Molnlycke Health Care AB:企業の戦略的SWOT分析
    Molnlycke Health Care AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • San Diego Gas & Electric Co:電力:M&Aディール及び事業提携情報
    Summary San Diego Gas & Electric Company (SDGE), a subsidiary of Sempra Energy is an energy service provider that offers electric generation, transmission and distribution services. The company also distributes natural gas. Its residential services include payment and bill assistance, start, stop, m …
  • Patara Pharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Patara Pharma Inc (Patara Pharma) is a clinical-stage biopharmaceutical company that develops novel therapies for the treatment of chronic inflammatory and fibrosis. The company develops anti-inflammatory therapeutics for lung diseases and immune disorders. It conducts clinical trials and in …
  • United Rentals Inc:戦略・SWOT・企業財務分析
    United Rentals Inc - Strategy, SWOT and Corporate Finance Report Summary United Rentals Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • PT. Asuransi Jiwasraya (Persero):企業の戦略・SWOT・財務分析
    PT. Asuransi Jiwasraya (Persero) - Strategy, SWOT and Corporate Finance Report Summary PT. Asuransi Jiwasraya (Persero) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • PRA Health Sciences Inc (PRAH):製薬・医療:M&Aディール及び事業提携情報
    Summary PRA Health Sciences Inc (PRA) is a contract research organization (CRO) which provides clinical development services. The company offers services such as phase I-IV study management, and embedded and functional outsourcing services. It offers solutions in bioanalytical laboratories, biometri …
  • Power Engineering Consulting 2 Joint Stock Company (TV2):企業の財務・戦略的SWOT分析
    Summary Power Engineering Consulting Joint Stock Company 2 (PECC2), a subsidiary of Vietnam Electricity is a power company that designs, investigates, supervises and constructs electric power projects and other industrial and civil utilities. The company provides consultancy services comprise prepar …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆